Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3321 – 3340
of
3979
Herpes Simplex Virus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/herpes-simplex-virus
Leishmaniasis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/leishmaniasis
Mycobacterium tuberculosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/mycobacterium-tuberculosis
Lamivudine (Epivir, 3TC)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-lamivudine-epivir
Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/appendix-table-1-antiretrovirals-available-fixed
Human Herpesvirus-8 Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human-herpesvirus
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections That Require Dosage Adjustment in Patients with Renal Insufficiency
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/dosing-recommendations-drugs-used
Appendix B: Human Papillomavirus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-human
Table 1. Primary Prophylaxis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/primary-prophylaxis-full
Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children with HIV
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/regimens-recommended-initial-therapy-antiretroviral-naive-children
Emtricitabine
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/emtricitabine
Mycobacterium tuberculosis Infection and Disease
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/mycobacterium
Appendix B: Hepatitis C Virus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-6
Panel Roster
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/panel-roster
Special Populations: Adolescents and Young Adults With HIV
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-adolescents-and
Table 3. Treatment
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-3-treatment
Antiretroviral Treatment Interruption in Children With HIV
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/antiretroviral-treatment-interruption-children-hiv
Introduction
https://clinicalinfo.hiv.gov/guidelines/perinatal/introduction
Introduction
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/introduction
Initiation of Antiretroviral Therapy
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/initiation-antiretroviral-therapy
Pagination
First page
«
Previous page
‹
…
Page
163
Page
164
Page
165
Page
166
Current page
167
Page
168
Page
169
Page
170
Page
171
…
Next page
›
Last page
»